From diagnostic odyssey to zero bleeds: Experts urge systemic reform in rare disease care

Experts call for early diagnosis, prophylaxis in hemophilia, improved MS policy frameworks, genomic testing access and ...
The Manila Times

InnoCare’s next-generation TRKi Zurletrectinib Receives Priority Review for the Treatment of Pediatric Patients with Solid Tumors in China

InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company for the treatment of cancer and autoimmune diseases, announced today that its next generation TRK inhibitor zurletrectinib (ICP-723) ...

It's not too late yet: genetic screening of newborns has begun in Russia

EADaily, March 2nd, 2026. Tomsk geneticists summed up the results of a large-scale three-year study covering the Siberian ...